These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28299631)

  • 1. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.
    Ogawa Y; Yanagisawa K; Uchiumi H; Ishizaki T; Mitsui T; Gouda F; Ieko M; Ichinose A; Nojima Y; Handa H
    Int J Hematol; 2017 Jul; 106(1):82-89. PubMed ID: 28299631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
    Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
    Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired hemophilia A: a review of recent data and new therapeutic options.
    Franchini M; Vaglio S; Marano G; Mengoli C; Gentili S; Pupella S; Liumbruno GM
    Hematology; 2017 Oct; 22(9):514-520. PubMed ID: 28441921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission.
    Ogawa Y; Yanagisawa K; Naito C; Uchiumi H; Ishizaki T; Shimizu H; Gohda F; Ieko M; Ichinose A; Handa H
    Int J Hematol; 2020 Apr; 111(4):544-549. PubMed ID: 31939075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A.
    Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J
    Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China.
    Ye N; Liu Z; Xu G; Wang X; Wu F; Xu X; Wu W
    Hematology; 2019 Dec; 24(1):631-636. PubMed ID: 31514689
    [No Abstract]   [Full Text] [Related]  

  • 7. Acquired hemophilia a: retrospective analysis of 49 cases from a single Chinese hemophilia center.
    Yang Y; Xue F; Shi H; Wang H; Zhang L; Ji L; Yang R
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):35-40. PubMed ID: 23677912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of 65 patients with acquired hemophilia A in Taiwan.
    Huang SY; Tsay W; Lin SY; Hsu SC; Hung MH; Shen MC
    J Formos Med Assoc; 2015 Apr; 114(4):321-7. PubMed ID: 25839765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors.
    Rubinger M; Houston DS; Schwetz N; Woloschuk DM; Israels SJ; Johnston JB
    Am J Hematol; 1997 Oct; 56(2):112-8. PubMed ID: 9326353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of CARE: a 6-year national registry of acquired haemophilia A in China.
    Sun B; Xue F; Feng Y; Sun J; Yu Z; Hou M; Zhang J; Zeng X; Zhao Y; Lian S; Huang M; Niu T; Cui Z; Wu J; Yang R
    Br J Haematol; 2019 Dec; 187(5):653-665. PubMed ID: 31372978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
    Knoebl P; Marco P; Baudo F; Collins P; Huth-Kühne A; Nemes L; Pellegrini F; Tengborn L; Lévesque H;
    J Thromb Haemost; 2012 Apr; 10(4):622-31. PubMed ID: 22321904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tipping point: The critical role of therapeutic apheresis in a case of refractory acquired hemophilia.
    Losos M; Scrape S; Joshi S; Shmookler A; Chen J
    J Clin Apher; 2017 Dec; 32(6):564-566. PubMed ID: 27646211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor eradication and treatment for acquired hemophilia A.
    Franchini M; Focosi D
    Expert Rev Hematol; 2024 Jun; 17(6):233-240. PubMed ID: 38708599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired hemophilia: a single-center survey with emphasis on immunotherapy and treatment-related side-effects.
    Delgado J; Villar A; Jimenez-Yuste V; Gago J; Quintana M; Hernandez-Navarro F
    Eur J Haematol; 2002 Sep; 69(3):158-64. PubMed ID: 12406009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder.
    Sakurai Y; Takeda T
    J Immunol Res; 2014; 2014():320674. PubMed ID: 24741588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of minor severe acquired haemophilia. Is there a rationale for immunoadsorption?
    Goldmann G; Marquardt N; Horneff S; Oldenburg J; Zeitler H
    Atheroscler Suppl; 2015 May; 18():74-9. PubMed ID: 25936308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort.
    Salaj P; Geierová V; Ivanová E; Loužil J; Pohlreichová V; Hrachovinová I; Dulíček P
    Haemophilia; 2020 Jul; 26(4):643-651. PubMed ID: 32590889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of congenital and acquired hemophilia].
    Higasa S
    Rinsho Ketsueki; 2017; 58(7):857-865. PubMed ID: 28781285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.